Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts.
Valent P, Akin C, Arock M, Gleixner KV, Greinix H, Hermine O, Horny HP, Ivanov D, Orfao A, Rabitsch W, Reiter A, Schulenburg A, Sotlar K, Sperr WR, Ustun C. Valent P, et al. Among authors: schulenburg a. Int J Mol Sci. 2023 Oct 12;24(20):15125. doi: 10.3390/ijms242015125. Int J Mol Sci. 2023. PMID: 37894806 Free PMC article. Review.
Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives.
Valent P, Sadovnik I, Peter B, Ivanov D, Schulenburg A, Hadzijusufovic E, Willmann M, Rülicke T, Herrmann H, Rabitsch W, Karlic H, Gleixner KV, Sperr WR, Hoermann G, Dahlhoff M, Pfeilstöcker M, Keil F, Lion T, Grunt TW. Valent P, et al. Among authors: schulenburg a. Expert Rev Hematol. 2023 Jul-Dec;16(9):659-670. doi: 10.1080/17474086.2023.2232545. Epub 2023 Jul 27. Expert Rev Hematol. 2023. PMID: 37493441 Review.
Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives.
Valent P, Hadzijusufovic E, Grunt T, Karlic H, Peter B, Herrmann H, Eisenwort G, Hoermann G, Schulenburg A, Willmann M, Hubmann R, Shehata M, Selzer E, Gleixner KV, Rülicke T, Sperr WR, Marian B, Pfeilstöcker M, Pehamberger H, Keil F, Jäger U, Zielinski C. Valent P, et al. Among authors: schulenburg a. Wien Klin Wochenschr. 2018 Sep;130(17-18):517-529. doi: 10.1007/s00508-018-1355-7. Epub 2018 Jul 13. Wien Klin Wochenschr. 2018. PMID: 30006759 Free PMC article. Review.
Neoplastic stem cells: a novel therapeutic target in clinical oncology.
Schulenburg A, Ulrich-Pur H, Thurnher D, Erovic B, Florian S, Sperr WR, Kalhs P, Marian B, Wrba F, Zielinski CC, Valent P. Schulenburg A, et al. Cancer. 2006 Nov 15;107(10):2512-20. doi: 10.1002/cncr.22277. Cancer. 2006. PMID: 17039500 Free article. Review.
Umbilical Cord Blood Transplantation Is a Feasible Rescue Therapeutic Option for Patients Suffering from Graft Failure after Previous Hematopoietic Stem Cell Transplantation.
Bojic M, Worel N, Sperr WR, Schellongowski P, Wohlfarth P, Schwarzinger I, Mitterbauer-Hohendanner G, Fischer G, Dieckmann KU, Lamm W, Leiner M, Schulenburg A, Mitterbauer M, Greinix HT, Kalhs P, Rabitsch W. Bojic M, et al. Among authors: schulenburg a. Oncology. 2016;90(3):160-6. doi: 10.1159/000443767. Epub 2016 Feb 13. Oncology. 2016. PMID: 26871562
Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.
Herrmann H, Sadovnik I, Eisenwort G, Rülicke T, Blatt K, Herndlhofer S, Willmann M, Stefanzl G, Baumgartner S, Greiner G, Schulenburg A, Mueller N, Rabitsch W, Bilban M, Hoermann G, Streubel B, Vallera DA, Sperr WR, Valent P. Herrmann H, et al. Among authors: schulenburg a. Blood Adv. 2020 Oct 27;4(20):5118-5132. doi: 10.1182/bloodadvances.2020001742. Blood Adv. 2020. PMID: 33085758 Free PMC article.
59 results